TREATMENT FOR PARKINSONIAN PATIENTS WITH MUTATIONS IN THE LRRK2 GENE

• 1. 作为激酶LRRK2调节剂用于治疗帕金森病的2-苯基氨基嘧啶衍生物 [P] . 中国专利： CN105801493B . 2018.09.21
• 2. 作为LRRK2调节剂用于治疗帕金森病的吡唑氨基嘧啶衍生物 [P] . 中国专利： CN106279202A . 2017-01-04
• 3. Methods for the treatment of Fabry disease in patients with G9331A mutations in the GLA gene [P] . 韩国专利： KR102004114B1 . 2019-07-26

  机译： GLA基因G9331A突变的患者治疗Fabry疾病的方法

• 4. Methods for the treatment of Fabry disease in patients with G9331A mutations in the GLA gene [P] . 韩国专利： KR20180119691A . 2018-11-02

  机译： GLA基因G9331A突变的患者治疗Fabry疾病的方法

• 5. The immunotherapy treatment about the patient having the tumor with high passenger gene mutation burden [P] . 韩国专利： KR20200086371A . 2020-07-16

  机译： 载客基因突变负担高的肿瘤患者的免疫治疗

• 1. Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21 [J] . Jiang-Yong Yu, Si-Fan Yu, Shu-Hang Wang, 癌症（英文版） . 2016,第004期
• 2. Gene mutations in a patient with chronic myelomonocytic leukemia and changes upon progression to acute myeloid leukemia and during treatment [J] . Jiaming Li, Sujiang Zhang 肿瘤学与转化医学（英文） . 2019,第001期
• 3. Characteristics of cancer susceptibility genes mutations in 282 patients with gastric adenocarcinoma [J] . Ke Ji, Sheng Ao, Liu He, 中国癌症研究（英文版） . 2020,第004期
• 4. Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients. [J] . Floris G, Cannas A, Solla P Parkinsonism & related disorders . 2009,第4期
• 5. Phenotypical Differences in Neuronal Cultures Derived via Reprogramming the Fibroblasts from Patients Carrying Mutations in Parkinsonian Genes LRRK2 and PARK2 [J] . Konovalova E. V., Novosadova E. V., Grivennikov I. A., Bulletin of experimental biology and medicine . 2015,第6期
• 6. Phenotypical Differences in Neuronal Cultures Derived via Reprogramming the Fibroblasts from Patients Carrying Mutations in Parkinsonian Genes LRRK2 and PARK2 [J] . Konovalova E. V., Novosadova E. V., Grivennikov I. A., Bulletin of experimental biology and medicine . 2015,第6期
• 7. Intratumor Heterogeneity of EGFR Activating Mutations in Advanced NSCLC Patients at Single-Cell Level [C] . Liu Yuefen International Conference on Biomedical Engineering, Machinery and Earth Science . 2018
• 8. Genetic Variation in the LRRK2 Gene and Response to Anti-TNF Therapy in Patients with IBD [D] . Blakely, Jaclyn. 2019
• 9. 123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations [O] . Francesc Valldeoriola, Carles Gaig, Africa Muxí, -1
• 10. 123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations [O] . Francesc Valldeoriola, Carles Gaig, Africa Muxí, 2011

• 1. Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing [J] . Omar Youssef ,Virinder Sarhadi ,Homa Ehsan . 世界胃肠病学杂志：英文版 . 2017,第47期
• 2. Analysis of known point mutations and SNPs in genes responsible for monogenic Parkinson’s disease in Russian patients [J] . Elena V. Filatova ,Maria I. Shadrina ,Ekaterina Y. Fedotova . 帕金森（英文） . 2013,第1期
• 3. 亚洲帕金森病患者ATP13A2基因突变分析 [C] . 宁玉萍 ,服部信孝 ,船山松 . 中国神经科学学会精神神经专业分会第四届全国学术会议暨中华医学遗传学会第七届全国精神病遗传学术会议 . 2007
• 4. 早发型帕金森病患者PRKN及LRRK2基因突变的临床特征分析 [A] . 何雨茜 . 2019